LP-284 Targets Non-Hodgkin’s Lymphoma and DNA Damage Repair Deficiency
June 12, 2023
we demonstrated the new acylfulvene compound LP-284 has anti-tumor activity including nanomolar potency in fifteen in vitro NHL cell lines and in vivo preclinical NHL models.”BUFFALO, NY- June 12,... read more